Federal scientists are closely studying H5N1 genetic sequences from California dairy workers in search of any dangerous ...

The European drugs regulator said on Friday it was reviewing anti hair-loss drugs, including Organon's Propecia and its ...

This summary outlines recent health-related developments, including expansions in the bird flu vaccine supply, regulatory ...

There are currently no recommendations for anyone to be vaccinated against bird flu and federal health officials note this is ...

As more farm workers get sick with avian influenza, the US federal government is putting $72 million toward strengthening its ...

A new study highlights risk factors for hospitalization and severe illness among adults with respiratory syncytial virus (RSV ...

The Center for Biomedical Advanced Research and Development Authority (BARDA) is giving $72 million to three drugmakers to ...

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...

California health officials yesterday announced the state's second H5N1 avian flu infection in a dairy farm worker who had no ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the ...

First discovered in chimpanzees in 1956 and children the following year, respiratory syncytial virus (RSV), isn’t new.

Sanofi (SNY), and CSL (CSLLY) win $72M U.S. contract to expand bird flu vaccine production amid fears of human transmission.